Evidence map›Paper›PMID 29104462›Full record

ArticleInternational journal of medical sciences2017

Association of

Shingo Nakamoto, Fumio Imazeki, Tatsuo Kanda, Shuang Wu, Masato Nakamura, Shin Yasui, Akinobu Tawada, Rintaro Mikata, Tetsuhiro Chiba, Makoto Arai and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Shingo NakamotoDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Japan.
Fumio ImazekiDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Japan.
Tatsuo KandaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Japan.
Shuang WuDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Japan.
Masato NakamuraDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Japan.
Shin YasuiDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Japan.
Akinobu TawadaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Japan.
Rintaro MikataDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Japan.
Tetsuhiro ChibaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Japan.
Makoto AraiDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Japan.
Osamu YokosukaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Japan.
Hiroshi ShirasawaDepartment of Molecular Virology, Graduate School of Medicine, Chiba University, Japan.
Chiba University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGenetic variation near the interferon lambda 3 (

aimsWe examined whether this genetic variation is associated with host lipids and treatment response.

methodsA total of 101 Japanese patients who had underwent liver biopsy before treatment with pegIFN and ribavirin for HCV genotype 1b infection were retrospectively analyzed for association between

resultsForty patients (40%) had liver steatosis before therapy. Patients with

conclusionsOur results confirmed that

Indexed as

AdultAgedAntiviral AgentsFatty LiverFemaleGenotypeHepatitis C, ChronicHumansInterferon-alphaInterferon LambdaInterferonsInterleukinsMaleMiddle AgedRetrospective StudiesRibavirinAntiviral AgentsInterferon-alphaInterferon Lambdainterferon-lambda, humanInterferonsInterleukinsRibavirinHepatic steatosisHepatitis C virusInterferon lambda 3PeginterferonRibavirin

Identifiers

PMID29104462
PMCPMC5666539
OpenAlexW2756351017

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.